The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Masitinib plus irinotecan for second line treatment of esophagogastric adenocarcinoma: An open label phase Ib/II trial.
 
Aziz Zaanan
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Sandrine Hiret
No Relationships to Disclose
 
Jean-Yves Douillard
No Relationships to Disclose
 
Olivier Bouche
Honoraria - Lilly
Consulting or Advisory Role - Roche Pharma AG
 
David Tougeron
No Relationships to Disclose
 
Thierry Lecomte
Consulting or Advisory Role - Celgene; Ipsen
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Celgene; Ipsen; Novartis
 
Céline Lepère
No Relationships to Disclose
 
Colin Mansfield
Employment - AB Science
Stock and Other Ownership Interests - AB Science
Patents, Royalties, Other Intellectual Property - AB Science
 
Alain Moussy
Employment - AB Science
Leadership - AB Science
Stock and Other Ownership Interests - AB Science
Patents, Royalties, Other Intellectual Property - AB Science
 
Patrice Dubreuil
Employment - AB Science
Stock and Other Ownership Interests - AB Science
Patents, Royalties, Other Intellectual Property - AB Science
 
Olivier Hermine
Stock and Other Ownership Interests - AB Science
Honoraria - AB Science
Research Funding - AB Science
Travel, Accommodations, Expenses - AB Science
 
Julien Taieb
No Relationships to Disclose